Skip Navigation



European Heart Journal Advance Access published online on October 24, 2007
European Heart Journal, doi:10.1093/eurheartj/ehm495
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/22/2799    most recent
ehm495v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zegers, E. S.
Right arrow Articles by Verheugt, F. W.A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zegers, E. S.
Right arrow Articles by Verheugt, F. W.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Hotline Sessions of the 29th European Congress of Cardiology

Erwin S. Zegers and Freek W.A. Verheugt*

Department of Cardiology, Heartlungcentre, University Medical Centre St Radboud, PO Box 9101, Nijmegen 6500 HB, The Netherlands

Received 26 September 2007; accepted 26 September 2007.

* Corresponding author. Tel: +31 24 3614533; fax: +31 24 3540537. E-mail address: e.zegers@cardio.umcn.nl

Key Words: Hotline Sessions • 29th European Congress of Cardiology

The first 150 words of the full text of this article appear below.

The 29th Congress of the European Society of Cardiology was held from 1 September to 5 September 2007 in Vienna, Austria. During three Hotline sessions, the preliminary results of 15 studies were presented. One trial has been published recently (ADVANCE, Lancet 2007;370:829–840). The results in this overview were collected from the presentations of the speakers, as well as from press handouts.

During the first Hotline Session, several issues were addressed. The first session started with the results of the 3CPO study (Efficacy of non-invasive ventilation in patients with acute Cardiogenic Pulmonary Oedema), presented by David Newby from Edinburgh, UK. This multicentre randomized controlled trial of the early management of patients with acute cardiogenic pulmonary oedema compared continuous positive airway pressure (CPAP) ventilation and non-invasive intermittent positive pressure ventilation (NIPPV) with standard oxygen therapy. In total, 1069 patients were recruited (mean age 78 years, 43% male), CPAP (n . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. Carlsson, S. K. James, J. Lindback, F. Schersten, T. Nilsson, U. Stenestrand, B. Lagerqvist, and for the SCAAR (Swedish Coronary Angiography and An
Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria
J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1389 - 1398.
[Abstract] [Full Text] [PDF]